Smurfit Westrock (SW) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
3 May, 2026Executive summary
Net sales reached $8,003 million for Q3 2025, up year-over-year, driven by the WestRock acquisition and an extra five days in the reporting period.
Adjusted EBITDA was $1,302 million with a 16.3% margin, supported by strong performance across all regions.
Net income rebounded to $245 million, reversing a prior year loss, and operating profit rose to $526 million.
Ongoing synergy realization, operational improvements, and asset optimization post-combination, including closure of uneconomic facilities and permanent headcount reduction of over 4,500.
Strong cash flow performance with operating cash of $1.1 billion and adjusted free cash flow of $579 million.
Financial highlights
Net sales for Q3 2025 were $8,003 million; adjusted EBITDA was $1,302 million with a 16.3% margin.
Adjusted free cash flow reached $579 million, up from $118 million year-over-year.
North America: Net sales $4.7 billion, adjusted EBITDA $810 million, margin 17.2%.
EMEA & APAC: Net sales $2.8 billion, adjusted EBITDA $419 million, margin 14.8%.
Latin America: Net sales $545 million, adjusted EBITDA $116 million, margin 21.3%.
Outlook and guidance
Full-year 2025 adjusted EBITDA guidance is $4.9–$5.1 billion, reflecting additional economic downtime in Q4.
2026 capital expenditures projected at $2.4–$2.5 billion to optimize assets and support growth.
Long-term targets to be announced in February 2026.
Latest events from Smurfit Westrock
- Q1 2026 saw steady sales, lower profits, and strong EBITDA guidance reaffirmed.SW
Q1 20264 May 2026 - Q2 2025 saw strong sales and EBITDA, but restructuring costs led to a net loss.SW
Q2 20253 May 2026 - Targets $7bn Adjusted EBITDA and ~19% margin by 2030, with strong capital returns and global growth.SW
Investor presentation11 Mar 2026 - 2025 saw robust results, strong governance, and key proposals for shareholder approval.SW
Proxy Filing11 Mar 2026 - AGM to vote on directors, compensation, auditor, and share issuance; board recommends approval.SW
Proxy Filing11 Mar 2026 - Q4 net sales $7.58B, $4.94B Adjusted EBITDA; 2026 EBITDA guidance $5–$5.3B.SW
Q4 202511 Feb 2026 - Merger creates global leader; Q2 net income falls, but integration and synergies drive outlook.SW
Q2 20242 Feb 2026 - Q3 sales hit $7.7B, Adjusted EBITDA $1.27B, but one-time costs led to a $150M net loss.SW
Q3 202417 Jan 2026 - Q4 net sales $7.5B, $1.17B EBITDA, $400M synergies, and 42% dividend increase achieved.SW
Q4 20248 Jan 2026